Bionik Laboratories Corp (BNKL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2023 | 03-2022 | 03-2021 | 03-2020 | 03-2019 | |
| Sales | 1,805 | 1,274 | 1,193 | 2,153 | 3,246 |
| Cost of Goods | 815 | 321 | 270 | 893 | 1,630 |
| Gross Profit | 990 | 953 | 924 | 1,260 | 1,616 |
| Operating Expenses | 6,630 | 11,247 | 14,531 | 13,318 | 11,733 |
| Operating Income | -4,825 | -9,973 | -13,337 | -11,164 | -9,487 |
| Interest Expense | 107 | 825 | 405 | 182 | 0 |
| Other Income | -14 | 390 | 122 | -13,671 | -1,069 |
| Pre-tax Income | -4,946 | -10,408 | -13,621 | -25,017 | -10,557 |
| Net Income Continuous | -4,946 | -10,408 | -13,621 | -25,017 | -10,557 |
| Net Income | $-4,946 | $-10,408 | $-13,621 | $-25,017 | $-10,557 |
| EPS Basic Total Ops | -0.72 | -1.78 | -2.66 | -5.61 | -4.47 |
| EPS Basic Continuous Ops | -0.72 | -1.78 | -2.66 | -5.61 | -4.47 |
| EPS Diluted Total Ops | -0.72 | -1.78 | -2.66 | -5.61 | -4.47 |
| EPS Diluted Continuous Ops | -0.72 | -1.78 | -2.66 | -5.61 | -4.47 |
| EPS Diluted Before Non-Recurring Items | -0.59 | -0.96 | -1.22 | -3.14 | -4.47 |
| EBITDA(a) | $-4,762 | $-9,871 | $-13,148 | $-10,784 | $-9,139 |